Table 2.
Mean peak area of lyso-Gb3-related biomarker in patient sample injections compared to control sample injections (n = 3) in positive mode (nd = “not detected”).
| Lyso-Gb3 Related Biomarker | Expected Mass (m/z) | Patient | Control-1 | Control-2 |
|---|---|---|---|---|
| lyso-Gb3 | 786.4487 | nd | nd | nd |
| lyso-Gb3 (−C2H4) | 758.4174 | nd | nd | nd |
| lyso-Gb3 (−C2H4 + O) | 774.4123 | nd | nd | nd |
| lyso-Gb3 (−H2) | 784.4331 | nd | nd | nd |
| yso-Gb3 (−H2 + O) | 800.4280 | nd | nd | nd |
| lyso-Gb3 (+O) | 802.4436 | nd | nd | nd |
| lyso-Gb3 (H2O2) | 820.4542 | nd | nd | nd |
| lyso-Gb3 (H2O3) | 836.4491 | nd | nd | nd |